Bloomberg News

Sumitomo’s Sunovion Unit Wins $18 Million in Mylan Patent Trial

February 13, 2012

Feb. 10 (Bloomberg) -- Sumitomo Sumitomo Chemical Co.’s Sunovion Pharmaceuticals unit won a $18 million verdict from Mylan Inc. in a patent-infringement trial over technology for asthma-treatment inhalers.

To contact the reporter on this story: Phil Milford in Wilmington, Delaware at

To contact the editor responsible for this story: Michael Hytha at

Race, Class, and the Future of Ferguson

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus